Phenytoin-induced pseudolymphoma syndrome: an immunologic study.


In vitro and in vivo immunologic studies were performed on a 28-year-old woman with phenytoin sodium-induced pseudolymphoma syndrome. During the acute phase of the syndrome, the patient appeared immunologically depressed. Six months after resolution of lymphadenopathy, repeat studies demonstrated a return to immunologic competence. In vitro studies of the… (More)


Cite this paper

@article{Charlesworth1977PhenytoininducedPS, title={Phenytoin-induced pseudolymphoma syndrome: an immunologic study.}, author={Ernest N Charlesworth}, journal={Archives of dermatology}, year={1977}, volume={113 4}, pages={477-80} }